论文部分内容阅读
本文报道头孢拉定治疗各种感染100例,其中呼吸道感染57例,消化道感染23例及泌尿道感染20例。剂量为静滴2q,bid或口服胶囊0.5,qid,疗程平均8±SD4d。其显效率分别为42％(24/57),26％(6/23)及50％(10/20);总有效率为88％。给药1-3d临床症状如发热、尿道刺激和腹痛明显消减,呼吸道症状也随体温下降而缓解。头孢拉定对大肠杆菌、克雷白杆菌、金黄色葡萄球菌所致的感染疗效较佳,对绿脓杆菌感染无效。副反应率为15％,以恶心、呕吐为多见。
This article reports the cefradine treatment of various infections in 100 cases, of which 57 cases of respiratory infections, gastrointestinal infections in 23 cases and 20 cases of urinary tract infections. The dose of intravenous infusion of 2q, bid or oral 0.5, qid, treatment average 8 ± SD4d. The effective rates were 42% (24/57), 26% (6/23) and 50% (10/20), respectively. The total effective rate was 88%. 1-3d clinical symptoms such as fever, urinary tract irritation and abdominal pain was significantly reduced, respiratory symptoms also decreased with the body temperature to ease. Cephradine against E. coli, Klebsiella, Staphylococcus aureus infections caused by better efficacy of Pseudomonas aeruginosa infection is invalid. Side effects were 15%, with nausea and vomiting as common.